Under Armour stock steadies in premarket after Fairfax lifts stake to 16.1% in fresh buys
31 December 2025
2 mins read

Under Armour stock steadies in premarket after Fairfax lifts stake to 16.1% in fresh buys

NEW YORK, December 31, 2025, 05:37 ET — Premarket

  • Under Armour Class A shares (UAA) were flat in premarket trading after a sharp jump in the prior session. 1
  • Fairfax-linked entities disclosed about $71 million in late-December purchases across Under Armour’s two share classes, a Form 4 showed. 2
  • A Schedule 13G filing showed Fairfax and affiliates now hold 16.1% of Under Armour’s Class A stock. 3

Under Armour’s Class A shares were flat in premarket trading on Wednesday at $5.14, after surging in the prior session on disclosures that Fairfax Financial and related entities had been buying the sportswear maker’s stock. 1

The buying matters because it comes with Under Armour still trying to rebuild investor confidence after a long stretch of choppy sales trends and restructuring actions, while its stock trades far below its highs of the past year. 4

Large purchases by a “10% owner” — SEC shorthand for a shareholder with at least a 10% stake — often draw traders’ attention because U.S. rules require that holder to disclose buying and selling quickly, reducing uncertainty about who is accumulating shares. 5

In a Form 4 filed late Monday, Fairfax-controlled entities reported buying a combined 15.68 million Under Armour shares between Dec. 22 and Dec. 29 for about $71.0 million, at weighted-average prices ranging roughly from $4.36 to $4.73. 5

The filing showed Fairfax and affiliates ended that period with 30.45 million Class A shares and 7.78 million Class C shares held indirectly through wholly owned subsidiaries. 2

A separate Schedule 13G amendment said Fairfax-linked reporting persons beneficially owned 30.45 million Class A shares, representing 16.1% of the class based on shares outstanding as of Oct. 31, 2025. (A Schedule 13G is the SEC filing large investors typically use to disclose stakes when they say they are not seeking control.) 6

In Tuesday’s regular session, Class A shares (UAA) closed up 7.53% at $5.14, while Class C shares (UA) gained 8.59% to $4.93; early Wednesday, UA slipped 0.61% in premarket to $4.90. 7

Under Armour’s move outpaced larger athleticwear names on the day, with Nike ending slightly lower while Deckers rose modestly, according to MarketWatch data. 8

Under Armour has two publicly traded share classes on the NYSE — UAA (Class A) and UA (Class C) — and both have been hovering near the lower end of their 52-week range, after touching a low of $4.13 and a high of $8.72. 4

The Baltimore-based company has been working through a turnaround under founder Kevin Plank, who returned as CEO in April 2024. “Eighteen months into its turnaround plan, Under Armour appears to be struggling to navigate both a challenging external environment and internal missteps,” said eMarketer analyst Sky Canaves. (Story: Reuters, Nov. 6) 9

Credit markets are also on watch: S&P Global placed Under Armour’s ratings on downgrade watch in late November, citing continued restructuring challenges and sales declines, and said it would resolve the watch placement within about 90 days depending in part on holiday sales and profitability. (Story: Reuters, Nov. 25) 10

On the Street, Under Armour’s analyst consensus remains cautious, with a “Hold” rating and an average 12-month price target of about $6.18, according to StockAnalysis. 11

For the session ahead, traders will watch whether the insider buying triggers follow-on stake disclosures and whether UAA can hold above the $5 level after Tuesday’s spike; the next quarterly results are not yet company-confirmed, but MarketBeat estimates a Feb. 5 report before the open based on past patterns. (Calendar: MarketBeat) 12

Stock Market Today

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

7 February 2026
Bank of America shares rose 2.89% Friday to $56.53, tracking a rally in U.S. financial stocks as the Dow closed above 50,000. The bank will redeem its Series DD preferred stock and related depositary shares on March 10 at $1,000 per share. CEO Brian Moynihan donated 100,000 shares on Feb. 4, a regulatory filing showed. Key U.S. jobs and inflation data are due next week after delays.
Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

7 February 2026
Oracle shares jumped 4.65% to $142.82 Friday, ending an eight-day slide but remaining down 22% since Jan. 27. The company has set up a $20 billion at-the-market stock program and completed a $25 billion senior notes sale to fund cloud expansion. Oracle’s liabilities stood at $174.5 billion as of Nov. 30, 2025, before the new financing. Investors remain focused on dilution risks and the pace of capacity growth.
Why Oriental Culture Holding OCG stock is moving again in premarket after a 23% jump
Previous Story

Why Oriental Culture Holding OCG stock is moving again in premarket after a 23% jump

Premium Bonds January 2026 draw date is set — here’s when NS&I results drop and why savers are rethinking
Next Story

Premium Bonds January 2026 draw date is set — here’s when NS&I results drop and why savers are rethinking

Go toTop